Effects of boosted tipranavir and lopinavir on body composition, insulin sensitivity and adipocytokines in antiretroviral-naive adults.
2008
Objectives: Thymidine-based nucleoside analogue reverse transcriptase inhibitors and some protease inhibitors of HIV are associated with lipoatrophy, relative central fat accumulation and insulin resistance. The latter associations have not been well evaluated prospectively in adults commencing antiretroviral therapy. We studied the effects of protease inhibitor-based antiretroviral regimens on body composition, insulin sensitivity and adipocytokine levels. Design: 48-week substudy of a randomized, open-label, three-arm trial. Setting: Hospital and community HIV clinics. Participants: 140 HIV-infected adults naive to antiretroviral therapy. Intervention: Tipranavir/ritonavir [500/200 mg twice a day (TPV/r200)] or [500/100 mg twice a day (TPV/r100)] or lopinavir/ritonavir [400/100 mg twice a day (LPV/r)], each with tenofovir+lamivudine. Main outcome measures: Body composition [dual-energy x-ray absorptiometry for limb fat; L4, abdominal computed tomography for visceral adipose tissue (VAT)]; and fasting metabolic parameters. The primary analysis was change in limb fat mass in each TPV/r group vs. LPV/r. Results: Limb fat increased in all three groups: LPV/r (1.17 kg) versus TPV/r200 (0.83 kg; P= 0.16) and TPV/r100 (0.41 kg; P= 0.07). VAT decreased in all groups: LPV/r (-3cm 2 ) vs. TPV/r200 (-9cm 2 ; P=0.04) and TPV/r100 (-6cm 2 ; P=0.40). No significant change in insulin sensitivity was observed, including by oral glucose tolerance testing. The increase in leptin levels was significantly correlated with the increase in limb fat mass (r=0.67; P<0.0001). Despite increased limb fat, adiponectin levels increased, but significantly more with TPV/r200 (+6010ng/ml; P<0.0001) or TPV/r100 (+4497ng/ml; P= 0.002) when compared with LPV/r (+1360ng/ml). Conclusion: Unlike many other antiretroviral regimens, TPV/r or LPV/r with tenofovirlamivudine increased subcutaneous fat without evidence for increasing visceral fat or insulin resistance over 48 weeks.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
26
References
28
Citations
NaN
KQI